Search Results - "Rubio Castellón, V."

PO-04 - A new genetic risk score for predicting venous thromboembolic events in cancer patients receiving chemotherapy by Martín, A.J. Muñoz, Ziyatdinov, A, Rubio, V. Castellón, Olmos, V. Pachón, Huerta, B. Morejón, Rodríguez, J. Calzas, Fernández, M. Salgado, de Castro, E. Martínez, Caro, R. Luque, Fernández, J.M. Soria

“…Background Venous thromboembolism (VTE) is one of the major causes of cancer-associated mortality. Risk for developing VTE increases when in chemotherapy,…”
Get full text

PO-87 Comparison of different clinical risk assessment models (RAMs) in ambulatory cancer patients receiving chemotherapy from the Oncothromb-02 study by Muñoz Martín, A., Ruiz Zamorano, M., Cárdenas Yebra, A., Ortega Morán, L., Ferrer Pérez, A.I., Rupérez Blanco, A.B., Rubio Pérez, J., Martínez-Galán, J., Font-Puig, C., Fernández Pérez, I., Pachón Olmos, V., Martínez de Castro, E., Quintanar Verdúgez, T., López, S., Rubio Castellón, V., Martínez-Pérez, A., Seguí, E., García Escobar, X., Salgado, M., Salas Pérez-Rasilla, E., Soria Fernández, J.M.

Get full text

Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2) by Sánchez Sánchez, R, Rodríguez Fernández, A, Gómez Río, M, Alkurdi Martínez, A, Castellón Rubio, V E, Ramos Font, C, Sánchez-Palencia Ramos, A, Delgado Pérez, J R, Llamas Elvira, J M

“…PURPOSETo evaluate the accuracy of integrated positron emission tomography with (18)F-fluoro-2-deoxy-D-glucose (FDG) and computed tomography (PET/CT) in…”
Get full text

Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2) by Sánchez Sánchez, R., Rodríguez Fernández, A., Gómez Río, M., Alkurdi Martínez, A., Castellón Rubio, V.E., Ramos Font, C., Sánchez-Palencia Ramos, A., Delgado Pérez, J.R., Llamas Elvira, J.M.

“…To evaluate the accuracy of integrated positron emission tomography with 18F-fluoro-2-deoxy- d-glucose (FDG) and computed tomography (PET/CT) in mediastinal…”
Get full text

176 Relation between methylation promoters gene and estrogen receptor (ERS1) and her2/neu status in breast cancer patients by Martinez-Galan, J, Torres, B. Torres, Del Moral Ávila, R, Bautista, J. Valdivia, Torres, M.I. Nuñez, Rubio, V. Castellon, Vicente, A. Gonzalez, Garcia, J. Soberino, Perez, J.R. Delgado, De Almodovar, M. Ruiz

Get full text